Hackpads are smart collaborative documents. Join Hackpad Now.

ankit pittewar

11 hours ago
Unfiled. Edited by ankit pittewar 11 hours ago
ankit p Hiv Drugs Market 2021 Global Industry Analysis, Potential Growth, Key Players
The global HIV/AIDS drugs market size is likely to derive growth form the increasing prevalence of the disease across the world. According to a report published by Fortune Business Insights, titled “HIV/AIDS Drugs Market: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 25,314.0 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 40,675.0 Mn by 2026, thereby exhibiting a CAGR of 6.1% in the forecast period
 
 
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/hiv-aids-drugs-market-101115
Leading Players operating in the Hiv Drugs Market are:
 
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
 
 
  • ViiV Healthcare
  • Gilead Sciences
  • Merck Sharp & Dohme
  • Bristol-Myers Squibb Company
  • Janssen Pharmaceuticals
  • Theratechnologies
  • Mylan Pharmaceuticals
  • Genentech
  • AbbVie
Detailed Table of Content:
 
1.  Introduction
1.1.  Research Scope
1.2.  Market Segmentation
1.3.  Research Methodology
1.4.  Definitions and Assumptions
2.  Executive Summary
3.  Market Dynamics
3.1.  Market Drivers
3.2.  Market Restraints
3.3.  Market Opportunities
4.  Key Insights
4.1.  Epidemiology of HIV/AIDS by Key Countries
4.2.  Overview of Pipeline Analysis
4.3.  Regulatory Scenario by Key Countries
4.4.  Pricing Analysis
4.5.  Key Strategies Employed by Market Leaders in Various Regions
4.6.  Overview of New Product Launches
5.  Global HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
5.1.  Key Findings / Summary
5.2.  Market Analysis, Insights and Forecast – By Drug Class
5.2.1.Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
5.2.2.Integrase Inhibitors
5.2.3.Combination HIV Medicines
5.2.4.Others
5.3.  Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1.Hospital Pharmacies
5.3.2.Retail Pharmacies
5.3.3.Online Pharmacies
5.3.4.Others
5.4.  Market Analysis, Insights and Forecast – By Region
5.4.1.North America
5.4.2.Europe
5.4.3.Asia Pacific
5.4.4.Rest of World
6.  North America HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
6.1.  Key Findings / Summary
6.2.  Market Analysis – By Drug Class
6.2.1.Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
6.2.2.Integrase Inhibitors
6.2.3.Combination HIV Medicines
6.2.4.Others
6.3.  Market Analysis – By Distribution Channel
6.3.1.Hospital Pharmacies
6.3.2.Retail Pharmacies
6.3.3.Online Pharmacies
6.3.4.Others
6.4.  Market Analysis – By Country
6.4.1.U.S.
6.4.2.Canada
7.  Europe HIV-AIDS Drugs Market Analysis, Insights and Forecast, 2015-2026
7.1.  Key Findings / Summary
7.2.  Market Analysis – By Drug Class
7.2.1.Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
7.2.2.Integrase Inhibitors
7.2.3.Combination HIV Medicines
7.2.4.Others
7.3.  Market Analysis – By Distribution Channel
7.3.1.Hospital Pharmacies
7.3.2.Retail Pharmacies
7.3.3.Online Pharmacies
7.3.4.Others
7.4.  Market Analysis – By Country/ Sub-Region
7.4.1.U.K.
7.4.2.Germany
7.4.3.France
7.4.4.Spain
7.4.5.Italy
7.4.6.Scandinavia
7.4.7.Rest of Europe
 
11 hours ago
Unfiled. Edited by ankit pittewar 11 hours ago
ankit p Neurovascular Devices Market: 2021 Worldwide Opportunities, Market Share
The global neurovascular devices market size is estimated to reach USD 4.28 billion by 2026, exhibiting a CAGR of 8.3% during the forecast period. One of the key drivers propelling the growth of this market is the increasing incidence of strokes on a global scale. According to the Brain Aneurysm Foundation, an estimated 6 million Americans each year suffer from cerebral aneurysms. The condition is also responsible for a half-million deaths globally each year. About 40% of ruptures result in death, and of those who survive, approximately 66% have some permanent brain damage. These neurovascular devices market trends along with the accessibility of new treatment options will substantively raise the demand for neurovascular devices in the forthcoming years.
 
Leading Players operating in the Neurovascular Devices Market are:
 
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
 
·  Medtronic
·  Penumbra, Inc.
·  Stryker
·  Terumo Corporation
·  Johnson & Johnson Services, Inc.
·  Merit Medical Systems
·  W. L. Gore & Associates, Inc.
·  MicroPort Scientific Corporation
 
·  Other Players
 
 
Detailed Table of Content:
 
1.  Introduction
1.1.  Research Scope
1.2.  Market Segmentation
1.3.  Research Methodology
1.4.  Definitions and Assumptions
2.  Executive Summary
3.  Market Dynamics
3.1.  Market Drivers
3.2.  Market Restraints
3.3.  Market Opportunities
4.  Key Insights
4.1.  Incidence of Strokes, By Key Regions/Countries, 2018
4.2.  New Product Launch, By Key Players
4.3.  Technological Advancements in Neurovascular Devices
4.4.  Key Industry Developments – Partnerships, Mergers and Acquisitions
5.  Global Neurovascular Devices Market Analysis, Insights and Forecast, 2015-2026
5.1.  Key Findings / Summary
5.2.  Market Analysis, Insights and Forecast – By Device Type
5.2.1.Stenting Systems
5.2.2.Embolization Devices
5.2.3.Neurothrombectomy Devices
5.2.4.Support Devices
5.3.  Market Analysis, Insights and Forecast – By Application
5.3.1.Cerebral Aneurysms
5.3.2.Ischemic Stroke
5.3.3.Others
5.4.  Market Analysis, Insights and Forecast – By End User
5.4.1.Hospitals
5.4.2.Specialty Clinics
5.4.3.Others
5.5.  Market Analysis, Insights and Forecast – By Region
5.5.1.North America
5.5.2.Europe
5.5.3.Asia Pacific
5.5.4.Latin America
5.5.5.Middle East & Africa
6.  North America Neurovascular Devices Market Analysis, Insights and Forecast, 2015-2026
6.1.  Key Findings / Summary
6.2.  Market Analysis, Insights and Forecast  – By Device Type
6.2.1.Stenting Systems
6.2.2.Embolization Devices
6.2.3.Neurothrombectomy Devices
6.2.4.Support Devices
6.3.  Market Analysis, Insights and Forecast  – By Application
6.3.1.Cerebral Aneurysms
6.3.2.Ischemic Stroke
6.3.3.Others
6.4.  Market Analysis, Insights and Forecast  – By End User
6.4.1.Hospitals
6.4.2.Specialty Clinics
6.4.3.Others
6.5.  Market Analysis, Insights and Forecast  – By Country
6.5.1.U.S.
6.5.2.Canada
7.  Europe Neurovascular Devices Market Analysis, Insights and Forecast, 2015-2026
7.1.  Key Findings / Summary
7.2.  Market Analysis, Insights and Forecast  – By Device Type
7.2.1.Stenting Systems
7.2.2.Embolization Devices
7.2.3.Neurothrombectomy Devices
7.2.4.Support Devices
7.3.  Market Analysis, Insights and Forecast  – By Application
7.3.1.Cerebral Aneurysms
7.3.2.Ischemic Stroke
7.3.3.Others
7.4.  Market Analysis, Insights and Forecast  – By End User
7.4.1.Hospitals
7.4.2.Specialty Clinics
7.4.3.Others
7.5.  Market Analysis, Insights and Forecast  – By Country/Sub-region
7.5.1.U.K.
7.5.2.Germany
7.5.3.France
7.5.4.Spain
7.5.5.Italy
7.5.6.Scandinavia
 
7.5.7.Rest of Europe
...
11 hours ago
Unfiled. Edited by ankit pittewar 11 hours ago
ankit p Global Blood Glucose Monitoring Systems Market: Report Highlights the Competitive Scenario with Impact of Drivers 
As per the International Diabetes Foundation, the number of adults suffering from diabetes was around 425 million and is expected to reach 630 million by 2045. The prevalence of diabetes is primarily increasing owing to the rapid adoption of sedentary lifestyle and unhealthy food habits. This further shows that the demand for blood glucose monitoring systems will increase, thereby driving the global blood glucose monitoring systems market. As per the report, the global market was valued at USD 10.09 Billion in the year 2018 and is projected to be worth USD 17.06 Billion by 2026. In addition to this, the global market is expected to exhibit a CAGR of 6.7% during the forecast period.
 
Key Players Operating in The Blood Glucose Monitoring Systems Market Include:
 
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
 
·       F. Hoffmann-La Roche Ltd.
·       Abbott
·       Ascensia Diabetes Care Holdings AG
·       Dexcom, Inc.
·       Medtronic
·       B. Braun Melsungen AG
·       Lifescan Inc.
·       Terumo Medical Corporation
·  DiamonTech GmbH
Detailed Table of Content:
 
. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Prevalence of Diabetes, By Key Countries/ Key Regions, 2018
4.2 Pricing Analysis, By Key Regions/ Key Market Players
4.3 New Product Launches, By Key Market Players
4.4 Detailed Product Mapping, By Key Market Players
4.4 Recent Industry Developments Such As Mergers & Acquisitions
5. Global Blood Glucose Monitoring Systems Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Device
5.2.1 Continuous Glucose Monitoring Systems (CGM)
5.2.2 Self-Monitoring Blood Glucose (SMBG) Systems
5.3. Market Analysis, Insights and Forecast – By Type
5.3.1 Invasive
5.3.2 Non-Invasive
5.4 Market Analysis, Insights and Forecast – By Modality
5.4.1 Wearable
5.4.2 Non- Wearable
5.5. Market Analysis, Insights and Forecast – By Distribution Channel
5.5.1 Institutional Sales
5.5.2 Retail Sales
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1 North America
5.6.2 Europe
5.6.3 Asia Pacific
5.6.4 Latin America
5.6.5 Middle East & Africa 
 
1 day ago
Unfiled. Edited by ankit pittewar 1 day ago
ankit p Coronavirus Outbreak: Hip Replacement Industry Fights Back with Well-defined Business Strategies
 
According to the report, the hip replacement market size is prognosticated to be worth USD 10.51 billion by the end of 2026 from USD 7.13 billion in 2018. The market is expected to grow at a CAGR of 5.0% within the forecast period of 2019 to 2026. As per current hip implants market trends, the market is dominated by hospitals and ambulatory centers segment, with respect to end-user. This is attributable to the rise in the number of hip arthroplasty implants in hospitals and the rapid adoption of robots for replacement surgeries.
The report is based on facts and figures gathered from secondary and primary research methods. It provides details of the market primarily focusing on growth drivers, restraints, trends, and opportunities. Various players and their key strategies such as product launches, company collaborations, mergers and acquisitions, investment in research and development, among others are listed in the report. These strategies will help players invest accordingly and thus maintain a strong foothold in the market competition.
Click here to get the short-term and long-term impact of COVID-19 on this Hip Replacement Market.
 
Detailed Table of Content:
•  Introduction
o  Research Scope
o  Market Segmentation
o  Research Methodology
o  Definitions and Assumptions
•  Executive Summary
•  Market Dynamics
o  Market Drivers
o  Market Restraints
o  Market Opportunities
•  Key Insights
Number of Hip Replacement Procedures – For Key Countries
Regulatory Scenario - For Key Countries/Regions
Reimbursement Scenario - For Key Countries/Regions
New Product Launches
Technological Advancements in Hip Replacement Market
Key Industry Developments - Mergers, Acquisitions and Partnerships
•  Global Hip Replacement Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast – By Procedure
§  Total Hip Replacement
§  Partial Hip Replacement
§  Revision & Hip Resurfacing
Market Analysis, Insights and Forecast – By End User
§  Hospitals & Ambulatory Surgery Centers
§  Orthopedic Clinics
§  Others
Market Analysis, Insights and Forecast – By Region
§  North America
§  Europe
§  Asia Pacific
§  Latin America
 
§  Middle East & Africa
 
1 day ago
Unfiled. Edited by ankit pittewar 1 day ago
ankit p mHealth Apps Market Size, Development, Key Opportunity, Application and Forecast to 2026
The global “mHealth apps market size 2020” is projected to reach USD 57.57 billion by 2026. Driven by the increasing number of novel product launches, the market will witness an impressive growth rate in the coming years. According to a report published by Fortune Business Insights, titled “mHealth Apps Market Size, Share & Industry Analysis, By App Type (Disease & Treatment Management, Wellness Management, Others), By Application (Monitoring Services, Fitness Solutions, Diagnostic Services, Treatment Services, Others), By Operating System (Google Play Store, Apple App Store, Others) and Regional Forecast, 2019-2026,” the market was worth USD 11.17 billion in 2018 and will exhibit a CAGR of 21.1% during the forecast period, 2019-2026.
 
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/mhealth-apps-market-102020
 
Market Segmentation
By App Type
•  Disease & Treatment Management
o  Healthcare Providers/Insurance
o  Medication Reminders 
o  Women Health & Pregnancy
o  Disease Specific
•  Wellness Management
o  Fitness
o  Lifestyle & Stress
o  Diet And Nutrition
•  Others
By Application
•  Monitoring Services
•  Fitness Solutions
•  Diagnostic Services
•  Treatment Services
•  Others
By Operating System Type
•  Google Play Store
•  Apple App Store
•  Others
By Geography
•  North America (U.S. and Canada)
•  Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
•  Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
•  Latin America (Brazil, Mexico, and Rest of Latin America)
 
•  Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
 
2 days ago
Unfiled. Edited by ankit pittewar 2 days ago
ankit p Growth Dynamics on Parkinson's Disease Drugs Market 2021-2026
 
The Global Parkinson's Disease Drugs Market Share is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled “Parkinson’s Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby exhibiting a CAGR of 8.1%.
 Key Players Operating in The Parkinson’s Disease Drugs Market Include:
 
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
 
·       Pfizer
·       Roche
·       Merck
·       Novartis
·       Orion Pharma
·       UCB
·       Teva Pharmaceutical
·       Vertical Pharmaceuticals
·       ACADIA Pharmaceuticals Inc.
·       Impax Laboratories
·       Lundbeck
 
 
Highlights of the Report:
 
·       In-depth analysis of various insights, namely, Parkinson’s Disease Drugs Market trends, growth drivers, opportunities, and other related challenges.
·       Comprehensive details of key market players, their core competencies, and Parkinson’s Disease Drugs Market share.
·       The potency of suppliers and buyers to make better business decisions.
·       Lists out the market size in terms of volume.
 
Detailed Table of Content:
 
·       Introduction
o   Research Scope
o   Market Segmentation
o   Research Methodology
o   Definitions and Assumptions
·       Executive Summary
·       Market Dynamics
o   Market Drivers
o   Market Restraints
o   Market Opportunities
o   Market Trends
·       Key Insights
o   Prevalence of Parkinson's Disease - For Key Countries, 2018
o   Regulatory Scenario - For Key Countries
o   Patent Snapshot
·       4.4 New Product Launch
o   Pipeline Analysis
o   Key Industry Developments -Mergers, Acquisitions and Partnerships
·       Global Parkinson's Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
o   Key Findings / Summary
o   Market Analysis, Insights and Forecast – By Drug Class
§  Decarboxylase Inhibitors
§  DopamineAgonists
§  Monoamine Oxidase Type B (MAO-B) Inhibitors
§  Catechol-O-Methyltransferase (COMT) Inhibitors
§  Others
o   Market Analysis, Insights and Forecast – By Route of Administration
§  Oral
§  Injection
§  Transdermal
o   Market Analysis, Insights and Forecast – By Distribution Channel
§  Hospital Pharmacy
§  Retail Pharmacy
§  Online Stores
o   Market Analysis, Insights and Forecast – By Region
§  North America
§  Europe
§  Asia Pacific
§  Latin America
 
§  Middle East & Africa
 
2 days ago
Unfiled. Edited by ankit pittewar 2 days ago
ankit p Pain Management Devices Market: Is Covid19 testing the healthcare industry? 
The Global Pain Management Devices Market Size will benefit from increasing regulatory approvals for neuromodulation devices in recent years. According to a report published by Fortune Business Insights, titled “Pain Management Devices Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 3,922.9 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,046.3 Mn by 2026, exhibiting a CAGR of 9.4%.
Segmentation of Pain Management Devices Market
By Product Type
·       Electrical Stimulation Devices
·       RF Ablation Devices
·       Neuromodulation Devices
·       Infusion Pumps
By Application
·       Musculoskeletal
·       Brain
·       Cancer
·       Neuropathy
By End User
·       Physiotherapy Centers
·       Hospitals and Clinics
By Geography
·       North America
·       Europe
 
·       Asia Pacific
 

Contact Support



Please check out our How-to Guide and FAQ first to see if your question is already answered! :)

If you have a feature request, please add it to this pad. Thanks!


Log in / Sign up